2 unknown, 1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Memantine Oral Tablet: new trials by email Literature Review of Memantine Oral Tablet trials Research Report on Memantine Oral Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease Memantine, Memantine Oral Tablet - Alzheimer Disease | Phase 4 | Completed | Carnot Laboratories | 105 | 2024-10-04 | 2026-02-18 |
| Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy Memantine Oral Tablet, Pioglitazone 15mg, Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) - Radiation Disease, Cognitive Impairment | Phase 2 | Not yet recruiting | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 67 | 2024-09-10 | 2024-09-19 |
| Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI Memantine Oral Tablet - Neurocognitive Dysfunction | Phase 3 | Recruiting | Tata Memorial Centre | 101 | 2024-02-22 | 2025-04-09 |
| Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease Memantine Oral Tablet, GV-971 capsule - Treatment, Efficacy | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 150 | 2022-07-01 | 2022-07-07 |
| Memantine for Refractory OCD Patients Memantine Oral Tablet, Placebo - Obsessive-Compulsive Disorder | Phase 3 | Unknown | University of Roma La Sapienza | 20 | 2021-09-01 | 2021-08-20 |
Alzheimer Disease (2) · Abnormalities, Radiation-Induced (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Obsessive-Compulsive Disorder (1)
Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1) · Carnot Laboratories (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Tata Memorial Centre (1) · University of Roma La Sapienza (1)
India (1) · Mexico (1)
Alberto Mimenza Alvarado, Dr. (1)
PMID 10465680, PMID 16490414, PMID 23063327, PMID 23525525, PMID 29100251, PMID 37166948, PMID 41673604